Search
Izuforant
go.drugbank.com/drugs/DB21571ExperimentalThe usage of the INN stem '-forant' in the name indicates that Izuforant is a histamine H4 receptor antagonist. Izuforant has a monoisotopic molecular weight of 333.03 Da.
Inixaciclib
go.drugbank.com/drugs/DB21584ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Inixaciclib is a cyclin dependant kinase inhibitor. Inixaciclib has a monoisotopic molecular weight of 480.24 Da.
Culmerciclib
go.drugbank.com/drugs/DB21600InvestigationalThe usage of the INN stem '-ciclib' in the name indicates that Culmerciclib is a cyclin dependant kinase inhibitor. Culmerciclib has a monoisotopic molecular weight of 446.23 Da.
Monzosertib
go.drugbank.com/drugs/DB21619InvestigationalThe usage of the INN stem '-sertib' in the name indicates that Monzosertib is a serine/threonine kinase inhibitor. Monzosertib has a monoisotopic molecular weight of 465.16 Da.
Votoplam
go.drugbank.com/drugs/DB21645InvestigationalThe usage of the INN stem '-plam' in the name indicates that Votoplam is a SMN2 gene splicing modulator. Votoplam has a monoisotopic molecular weight of 419.22 Da.
Potrasertib
go.drugbank.com/drugs/DB21682ExperimentalThe usage of the INN stem '-sertib' in the name indicates that Potrasertib is a serine/threonine kinase inhibitor. Potrasertib has a monoisotopic molecular weight of 564.19 Da.
Tigemocoxib
go.drugbank.com/drugs/DB21699ExperimentalThe usage of the INN stem '-coxib' in the name indicates that Tigemocoxib is a selective cyclo-oxygenase inhibitor. Tigemocoxib has a monoisotopic molecular weight of 334.06 Da.
Lamifiban
go.drugbank.com/drugs/DB20451ExperimentalLamifiban has a monoisotopic molecular weight of 468.2 Da. … The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).
Lotrafiban
go.drugbank.com/drugs/DB20872ExperimentalLotrafiban has a monoisotopic molecular weight of 428.24 Da. … The usage of the INN stem '-fiban' in the name indicates that Lotrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).
SBT-100
go.drugbank.com/drugs/DB17215ExperimentalSBT-100 is an anti-signal transducer and activator of transcription 3 (STAT3) B VHH13 single-domain antibody (sdAb). … It was granted orphan drug designation by the FDA for the treatment of pancreatic cancer and osteosarcoma.[L44131,L44136]